Login / Signup

Importance of triple tumor markers as biomarkers in patients with pancreatic ductal adenocarcinoma.

Tadataka TakagiMinako NagaiSatoshi NishiwadaTaichi TeraiSatoshi YasudaYasuko MatsuoShunsuke DoiYuichiro KoharaMasayuki Sho
Published in: Annals of gastroenterological surgery (2022)
The combined evaluation of three tumor markers may provide useful information for the treatment of patients with PDAC.
Keyphrases
  • healthcare
  • combination therapy
  • replacement therapy